- Investing Ideas
- Hong Kong Pharmaceuticals & Biotech Undervalued Solid Performers
Hong Kong Pharmaceuticals & Biotech Undervalued Solid Performers
Results
3
Companies meeting several financial criteria and filtered from the entire market.
3 companies
Hansoh Pharmaceutical Group
Market Cap: HK$238.3b
An investment holding company, engages in the research, development, production, and sale of pharmaceutical products in the People’s Republic of China.
3692
HK$39.36
7D
20.9%
1Y
66.1%
Genscript Biotech
Market Cap: HK$27.0b
An investment holding company, engages in the manufacture and sale of life science research products and services in the United States of America, Europe, Mainland China, Europe, Asia Pacific, and internationally.
1548
HK$12.36
7D
11.4%
1Y
1.3%
United Laboratories International Holdings
Market Cap: HK$20.8b
An investment holding company, engages in the research and development, manufacture, distribution, and sale of pharmaceutical products.
3933
HK$10.54
7D
3.8%
1Y
-25.8%